19-Jun-2020 | Facts and Factors
According to the Facts and Factors report, the global suramin sodium market size was worth around USD 135 million in 2022 and is predicted to grow to around USD 190 million by 2030 with a compound annual growth rate (CAGR) of roughly 5.00% between 2023 and 2030.
Suramine is used to treat sleeping sickness in humans with trypanosoma. This is mainly used to treat early-African trypanosomiasis caused by the Trypanosoma brucei rhodesian and Trypanosoma brucei gambiense central nervous system. Trypanosoma brucei rhodesiense is considered the main line therapy and secondary line therapy for trypanosoma brucei gambiense, in which first line pentamidine is prescribed.
Browse the full “Suramin Sodium Market By Application (Antitumor Drug, Antiviral Drugs, and Immunomodulator): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2023–2030" https://www.fnfresearch.com/suramin-sodium-market-by-application-antitumor-drug-antiviral-1248
Suramine is not bioavailable by mouth, and is intravenously administered. Inflammation or necrosis of the local tissue may lead to intramuscular and subcutaneous administration. Suramine, which is around 99-98 per cent serum bound protein, has an average half-life of 41-78 days for 50 days, while suramine pharmacokinetics that differ significantly between single patients. Suramine does not spread easily to the cerebral fluid, and its tissue concentration is less than its plasma concentration. Suramine is not metabolized widely and is excreted into the kidneys about 80 per cent.
Suramine is selected through a receptor-mediated endocytosis of medicinal products associated with low-density lipoproteins and to a lesser extent with other serum proteins. Once combined with proteins in parasites, especially trypanosomal glycolytic enzymes, suramine inhibits energy metabolism.
The Antiviral Drugs-segment was the largest segment of the market in 2019 on the basis of application. It is used as part of a SSRI combination therapy and has shown positive results, leading to more physicians preferring such drugs. Anticonvulsants act as a good mood stabiliser for illness by reducing the symptoms of fever and amnesia.
North America continues to dominate the global market for the treatment of bipolar disorders. The Asia Pacific market is expected to rise at a faster rate of growth as a result of increased awareness among people, increased investment in R&D, the use of skilled labor to produce products and increased investment by the pharmaceutical industry.
Report Scope
Report Attribute |
Details |
Market Size in 2022 |
USD 190 Million |
Projected Market Size in 2030 |
USD 190 Million |
CAGR Growth Rate |
5.00% CAGR |
Base Year |
2022 |
Forecast Years |
2023-2030 |
Key Market Players |
BOC Science, MP Biomedicals VWR, Cayman Chemical, Sigma-Aldrich, Stemcell Technologies, and Others |
Key Segment |
By Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs.Explore purchase options |
Some of the leading players in the global market include
BOC Science, MP Biomedicals VWR, Cayman Chemical, Sigma-Aldrich, Stemcell Technologies and Others.
This report segments the Suramin Sodium market as follows:
By Application Segmentation Analysis
- Antitumor Drug
- Antiviral Drugs
- Immunomodulator
By Regional Segmentation Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
